openPR Logo
Press release

Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022

07-11-2017 12:26 PM CET | Health & Medicine

Press release from: Kuick Resarch

Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022

For Report Sample Contact: or +91-11-47067990

Report Table of Contents

Introduction to Cell Therapy

Necessity for Cell Therapy Treatment
2.1 Emergence of Stem Cell Research
2.2 Benefits of Using the Stem Cell for Research and Treatment

Application of Stem Cells in Cell Therapy
3.1 Stem Cells Ability to Differentiate
3.1.1 Totipotent Stem Cells
3.1.2 Pluripotent Stem Cells
3.1.3 Multipotent Stem Cells
3.1.4 Unipotent Stem Cells
3.2 Origin of Stem Cells
3.2.1 Embryonic Stem Cells
3.2.2 Adult Stem Cells
3.2.3 Induced Pluripotent Stem Cells (iPSCs)

Applications of Cell Therapy by Therapeutic Area
4.1 Cell Therapy for Cardiovascular Diseases
4.2 Cell Therapy for Neurological Disorders
4.3 Cell Therapy for Inflammatory Diseases
4.4 Cell Therapy for Diabetes
4.5 Cell Therapy for Cancer
4.6 Cancer Stem Cells Therapy
4.6.1 Therapies of Targeting the Cancer Stem Cells Targeting the Surface Markers Targeting the Signal Cascades Targeting the Microenvironment

Mechanism of Cell Therapy
5.1 Two Major Mechanism Principles of Stem Cell Based Therapy
5.1.1 Interaction of Modified Cells with Body Stem Cell Paracrine Actions in Heart Repair
5.1.2 Mechanism of Regenerative Cell Therapy Regenerative Medicine Therapies for Diabetes
5.2 Mechanism of Action in Alzheimer’s Diseases

Delivery Method of Cell Based Therapy
6.1 Outline to Delivery Methods
6.2 Direct Delivery Methods
6.2.1 Intravascular Infusions
6.2.2 Trans- Mucosal Delivery
6.3 Indirect Delivery of the Cells by Using the Carrier
6.3.1 Natural Biomaterials
6.3.2 Synthetic Biomaterials

Mechanism of Cell Therapy Treatment
7.1 Allogeneic Stem Cell Therapy
7.2 Autologous Stem Cell Therapy

Global Cell Therapy Market Overview
8.1 Current Market Scenario
8.2 Current Trends of Cell Therapy in Global Market
8.3 Global Cell Therapies Clinical Pipeline Overview

Global Cell Therapy Market by Region
9.1 North America
9.2 Europe
9.3 Asia
9.4 Rest of the World

Global Cell Therapy Market Dynamics
10.1 Favorable Market Parameters
10.2 Factors Limiting Market Growth

Global Cell Therapy Market Future Prospect

Global Cell Therapies Clinical Pipeline by Company, Indication and Phase
12.1 Unknown
12.2 Research
12.3 Preclinical
12.4 Clinical
12.5 Phase-0
12.6 Phase-I
12.7 Phase-I/II
12.8 Phase-II
12.9 Phase-II/III
12.10 Phase-III
12.11 Preregistration
12.12 Registered

Marketed Cell Therapies Clinical Insight by Company and Indication
13.1 T-Lymphocyte Cell Therapy (Immuncell-LC)
13.2 Muscle-Derived Autologous Stem Cell Therapy (MyoCell and MyoCell SDF-1)
13.3 Azficel-T (Laviv)
13.4 Sipuleucel-T (Provenge)
13.5 Placental Derived Mesenchymal Stem Cell Therapy - Osiris Therapeutics
13.6 Remestemcel-L (Prochymal and TEMCELL HS Inj.)
13.7 Autologous Mesenchymal Stem Cell Therapy andndash; Pharmicell
13.8 Autologous Cultured Chondrocytes (MACI)
13.9 Mesenchymal Stem Cell Therapy for Cartilage Repair (Cartistem)
13.10 Leukocyte Cell Therapy (CureXcell)
13.11 Adipose Stem Cell Therapy (Adipocell (Anterogen), Cupistem and Queencell)
13.12 Allogeneic Cultured Keratinocytes and Fibroblasts (Gintuit)
13.13 Autologous Cultured Chondrocyte Implant (Carticel)
13.14 Autologous Cultured Chondrocytes (CHONDRON)
13.15 Autologous Chondrocytes (BioCart and BioCartII)
13.16 Amniotic Cell Therapy (NuCel)
13.17 Dendritic Cell-Activated Cytokine-Induced Killer Cells - Shanghai Jia Fu Medical
13.18 Autologous Cultured Chondrocytes (Chondrotransplant DISC)
13.19 Autologous Cultured Myoblasts and Fibroblasts (Urocell)
13.20 Human Skin Replacement (CellSpray and CellSpray XP)

Competitive Landscape
14.1 AlloCure
14.2 Arteriocyte Medical Systems
14.3 Athersys Inc.
14.4 Baxter Healthcare Corporation
14.5 Bone Therapeutics
14.6 Celgene Corporation
14.7 Cell Medica
14.8 Cellerant Therapeutics
14.9 FibrocellScinence
14.10 Forticell Bioscience
14.11 Genzyme Corporation
14.12 Green Cross Cell
14.13 Histogenics Corporation
14.14 InnovacellBiotechnologie AG
14.15 Intrexon Corporation
14.16 Intercytex
14.17 ISTO Technologies
14.18 Macrocure
14.19 Mesoblast
14.20 Molmed
14.21 Nuo Therapeutics Inc
14.22 OmniCyte
14.23 Opexa Therapeutics
14.24 Organogenesis
14.25 Pharmicell
14.26 TCA Cellular Therapy
14.27 Stem Cell Inc.
14.28 Teva Pharmaceuticals
14.29 Tigenix
14.30 Vericel Corporation

Download Report:

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022 here

News-ID: 618698 • Views: 797

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases

More Releases for Cell

Single Cell Analysis Market
Single Cell Analysis Market Size Worth $ 4,752.19 Million By 2026 | CAGR: 18.4% The global Single Cell Analysis market size is expected to reach USD 4,752.19 million by 2026 according to a new study by WhipSmart MI Research. The report “Single Cell Analysis Market By Product (Consumables and Instruments), Cell Type (Human, Microbial and Animal), Technique (Flow Cytometers, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry and Other Techniques), Application
Fuel Cell Vehicle Market
The report aims to provide an overview of the global Fuel Cell Vehicle Market with detailed market segmentation by technology, vehicle type, and geography. The global fuel cell vehicle market is expected to witness high growth during the forecast period. The fuel cell vehicle market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market. Get Sample Copy of
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of